| Identification | More | [Name]
ETHYL 3-CHLOROBENZOYLFORMATE | [CAS]
62123-73-3 | [Synonyms]
(3-CHLOROPHENYL)GLYOXYLIC ACID ETHYL ESTER
ETHYL 3-CHLOROBENZOYLFORMATE
(3-Chlorophenyl)oxoacetic acid ethyl ester | [Molecular Formula]
C10H9ClO3 | [MDL Number]
MFCD01319616 | [Molecular Weight]
212.63 | [MOL File]
62123-73-3.mol |
| Safety Data | Back Directory | [Symbol(GHS) ]
GHS07 | [Signal word ]
Warning | [Hazard statements ]
H315-H319-H335 | [Precautionary statements ]
P261-P305+P351+P338 | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . |
| Hazard Information | Back Directory | [Synthesis]
GENERAL METHODS: 3-Chlorobenzoylacetonitrile (1.0 mmol) and PIDA (2.2 mmol) were dissolved in ethanol (8 mL), and the reaction was stirred under reflux conditions for 0.5 hours. The reaction process was monitored by thin layer chromatography (TLC). After completion of the reaction, the reaction mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent ratio 20:1 petroleum ether/ethyl acetate) to afford the target product ethyl 3-chlorobenzoylformate. Note: The solvent used in this synthesis step is methanol (MeOH). | [References]
[1] Tetrahedron Letters, 2015, vol. 56, # 24, p. 3793 - 3795 |
|
| Company Name: |
Tetranov Biopharm
|
| Tel: |
13526569071 |
| Website: |
http://www.leadmedpharm.com/index.html |
|